Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Preissner

Showing results (191-200 of 200) with videos related to

Pageof 20
Sort By:
You have reached the last page of results.This site can display upto 200 results.
Biomedicines|July 29, 2023
DRD2, DRD3, and HTR2A Single-Nucleotide Polymorphisms Involvement in High Treatment Resistance to Atypical Antipsychotic DrugsAntonio Del Casale, Maurizio Simmaco, Martina Nicole Modesti, et al.
Journal of Personalized Medicine|June 2, 2021
Evaluation of Drug-Drug Interactions in EGFR-Mutated Non-Small-Cell Lung Cancer Patients during Treatment with Tyrosine-Kinase InhibitorsMario Occhipinti, Marta Brambilla, Giulia Galli, et al.
Nucleic Acids Research|November 13, 2012
SynSysNet: integration of experimental data on synaptic protein-protein interactions with drug-target relationsJoachim von Eichborn, Mathias Dunkel, Björn O Gohlke, et al.
NPJ Breast Cancer|August 2, 2024
Author Correction: Clinical impact of drug-drug interactions on abemaciclib in the real-world experience of AB-ITALY studySimone Scagnoli, Simona Pisegna, Angela Toss, et al.
NPJ Breast Cancer|July 17, 2024
Clinical impact of drug-drug interactions on abemaciclib in the real-world experience of AB-ITALY studySimone Scagnoli, Simona Pisegna, Angela Toss, et al.
The European Respiratory Journal|March 23, 2023
Cystic fibrosis transmembrane conductance regulator modulators attenuate platelet activation and aggregation in blood of healthy donors and COVID-19 patientsErik Asmus, Weronika Karle, Markus C Brack, et al.
JCI Insight|June 29, 2021
IL-13 is a driver of COVID-19 severityAlexandra N Donlan, Tara E Sutherland, Chelsea Marie, et al.
Medrxiv : the Preprint Server for Health Sciences|March 10, 2021
IL-13 is a driver of COVID-19 severityAlexandra N Donlan, Tara E Sutherland, Chelsea Marie, et al.
European Heart Journal|April 28, 2017
CardioScape mapping the cardiovascular funding landscape in EuropeAxel Radlach Pries, Anastasia Naoum, Helmut Habazettl, et al.
Science (New York, N.Y.)|December 2, 2017
The target landscape of clinical kinase drugsSusan Klaeger, Stephanie Heinzlmeir, Mathias Wilhelm, et al.
Pageof 20

Showing results (191-200 of 200) with videos related to

Sort By:
Pageof 20
You have reached the last page of results.This site can display upto 200 results.
Biomedicines|July 29, 2023
DRD2, DRD3, and HTR2A Single-Nucleotide Polymorphisms Involvement in High Treatment Resistance to Atypical Antipsychotic DrugsAntonio Del Casale, Maurizio Simmaco, Martina Nicole Modesti, et al.
Journal of Personalized Medicine|June 2, 2021
Evaluation of Drug-Drug Interactions in EGFR-Mutated Non-Small-Cell Lung Cancer Patients during Treatment with Tyrosine-Kinase InhibitorsMario Occhipinti, Marta Brambilla, Giulia Galli, et al.
Nucleic Acids Research|November 13, 2012
SynSysNet: integration of experimental data on synaptic protein-protein interactions with drug-target relationsJoachim von Eichborn, Mathias Dunkel, Björn O Gohlke, et al.
NPJ Breast Cancer|August 2, 2024
Author Correction: Clinical impact of drug-drug interactions on abemaciclib in the real-world experience of AB-ITALY studySimone Scagnoli, Simona Pisegna, Angela Toss, et al.
NPJ Breast Cancer|July 17, 2024
Clinical impact of drug-drug interactions on abemaciclib in the real-world experience of AB-ITALY studySimone Scagnoli, Simona Pisegna, Angela Toss, et al.
The European Respiratory Journal|March 23, 2023
Cystic fibrosis transmembrane conductance regulator modulators attenuate platelet activation and aggregation in blood of healthy donors and COVID-19 patientsErik Asmus, Weronika Karle, Markus C Brack, et al.
JCI Insight|June 29, 2021
IL-13 is a driver of COVID-19 severityAlexandra N Donlan, Tara E Sutherland, Chelsea Marie, et al.
Medrxiv : the Preprint Server for Health Sciences|March 10, 2021
IL-13 is a driver of COVID-19 severityAlexandra N Donlan, Tara E Sutherland, Chelsea Marie, et al.
European Heart Journal|April 28, 2017
CardioScape mapping the cardiovascular funding landscape in EuropeAxel Radlach Pries, Anastasia Naoum, Helmut Habazettl, et al.
Science (New York, N.Y.)|December 2, 2017
The target landscape of clinical kinase drugsSusan Klaeger, Stephanie Heinzlmeir, Mathias Wilhelm, et al.
Pageof 20